Navigation Links
Eyeforpharma's Marketing Summit is shaping up to be the biggest event of its kind ever

Pharma’s Successful changing marketing approaches

LONDON, September 8, 2008 / b3c newswire /  – The looming recession certainly does not seem to have hit the European pharmaceutical industry yet.  With more than twice as many registered attendees as in past years, eyeforpharma’s upcoming Marketing Summit Europe, October 20-21 in Zurich is shaping up to be the biggest event of its kind ever.

Companies obviously know that thriving in today’s market means staying on top of their game and perhaps nowhere is that more important than in the rapidly changing pharmaceutical space.

Ultimately, the most successful pharmaceutical companies,  says Michael Zaiac, assistant vice president medical affairs EMEA at Wyeth, will be those who invest heavily in understanding the industry’s new stakeholders – especially patients, payers and policy makers – and employ an early feedback loop into their clinical discovery and development programs to steer products toward better meeting the needs of these stakeholders.

Companies that are quick on the uptake and willing to invest in the necessary skill sets to connect with these new customers, by either acquiring them from outside or training existing employees, Zaiac says, can positively differentiate themselves from their competitors and bring products to market more successfully.

Baba Awopetu, Manager of Brand Strategy EMEA at Stryker, says more stakeholders mean a more complex and complicated environment, and pharma marketers must consider where the power base lies and how much influence each group has given a company’s specific circumstances. Companies may find they have primary and secondary stakeholders, depending on the therapy area, product lifecycle or other factors, he suggests.

With a wider audience, pharmas will need to focus, prioritize and better target their messages, Awopetu says. “We have to cover a lot more with less, so our messages must be better targeted and our marketing efficiency is being forced to improve,” he says.

To learn more about marketing to pharma’s changing customer base, join Zaiac and Awopetu, who will be speaking and chairing sessions at eyeforpharma’s Marketing Summit Europe, October 20-21 in Zurich. For additional details or to register, visit

b3c newswire

Related biology technology :

1. European EMEA Acceptance of Marketing Authorization Application Filing for SNT-MC17 in Friedreichs Ataxia by Santhera
2. InterCure and Omron Healthcare (UK) Ltd. Announce Marketing Collaboration for Hypertension Market in United Kingdom
3. Operon Biotechnologies and DNA2.0 Announce Co-Marketing and Technology Development Partnership
4. Microbia and Forest Laboratories Announce Linaclotide Co-Development and Co-Marketing Collaboration
5. Phlo Affiliate Hires Chief Marketing Officer With Extensive Global Experience
6. Communicating Clinical Trial Data: Timing Remains Key Challenge for Marketing Teams
7. Bioenergy Life Science and Integrative Therapeutics, Inc. Form Exclusive Co-Marketing Alliance
8. Lantibio and TRB Chemedica Announce Licensing Agreement with Alcon for US Development and Marketing of Dry Eye Drug
9. Phlo Affiliate Names Director Of Marketing
10. Southern Research Expands Sales and Marketing Agreement with Absorption Systems to Service European Market
11. Natural Nutrition Launches International Marketing Campaign for New All Natural Analgesic: BLUE LIGHTNING(TM) Fast Pain Relief
Post Your Comments:
(Date:11/25/2015)... 25, 2015 Orexigen® Therapeutics, Inc. (Nasdaq: ... a fireside chat discussion at the Piper Jaffray 27th ... . The discussion is scheduled for Wednesday, December 2, ... .  A replay will be available for 14 days ... , Julie NormartVP, Corporate Communications and Business Development , ...
(Date:11/24/2015)... -- Cepheid (NASDAQ: CPHD ) today announced that ... and invited investors to participate via webcast. ... 1, 2015 at 11.00 a.m. Eastern Time --> ... 1, 2015 at 11.00 a.m. Eastern Time --> ... NY      Tuesday, December 1, 2015 at 11.00 ...
(Date:11/24/2015)... CITY , Nov. 24, 2015 /PRNewswire/ - Aeterna ... request of IIROC on behalf of the Toronto Stock ... news release there are no corporate developments that would ... --> --> About ... . --> Aeterna Zentaris is ...
(Date:11/24/2015)... -- SHPG ) announced today that Jeff Poulton ... th Annual Healthcare Conference in New York City ... EST (1:30 p.m. GMT). --> SHPG ) announced today ... the Piper Jaffray 27 th Annual Healthcare Conference in ... 2015, at 8:30 a.m. EST (1:30 p.m. GMT). --> ...
Breaking Biology Technology:
(Date:11/10/2015)... , Nov. 10, 2015 ... biometrics that helps to identify and verify the ... is considered as the secure and accurate method ... of a particular individual because each individual,s signature ... results especially when dynamic signature of an individual ...
(Date:11/2/2015)... , Nov. 2, 2015  SRI International has been ... provide preclinical development services to the National Cancer Institute ... will provide scientific expertise, modern testing and support facilities, ... preclinical pharmacology and toxicology studies to evaluate potential cancer ... The PREVENT Cancer Drug Development Program is an ...
(Date:10/29/2015)... Mich. , Oct. 29, 2015  Rubicon ... Genomics for U.S. distribution of its DNA library ... kit and Rubicon,s new ThruPLEX Plasma-seq kit. ThruPLEX ... enable the preparation of NGS libraries for liquid ... for diagnostic and prognostic applications in cancer and ...
Breaking Biology News(10 mins):